12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Aldeyra Therapeutics Inc ALDX
$1.54
▼ -3.75%
($-0.06)
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$1.62
Prev Close
$1.60
Day Range
$1.52 – $1.63
52W Range
$1.07 – $6.18
Market Cap
$92.89M
Beta
1.21
EPS (TTM)
$-0.46
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-05-02 |
| Shares Out. | 60,320,000 |
| Website | aldeyra.com/ ↗ |
| Phone | 13026365400 |
| Employees | 7 |
| Net Income | -$3.5M |
| Total Assets | $66.5M |
| Total Liabilities | $24.3M |
| Equity | $42.2M |
About Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Aldeyra Therapeutics Inc is a publicly traded company under the ticker symbol ALDX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-07-01)